These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem]. Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339 [No Abstract] [Full Text] [Related]
10. Persistence of medial hyalinosis of small vessels in an allograft after discontinuation of cyclosporine. Bastani B; Amin K; Salinas-Madrigal L Ann Pharmacother; 2004; 38(7-8):1322-3. PubMed ID: 15173553 [No Abstract] [Full Text] [Related]
11. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? Morozumi K; Sugito K; Oda A; Takeuchi O; Fukuda M; Usami T; Oikawa T; Fujinami T; Koyama K; Takeda A; Yoshida A; Haba T; Tominaga Y; Uchida K; Yokoyama I; Takagi H Transplant Proc; 1996 Apr; 28(2):1076-8. PubMed ID: 8623232 [No Abstract] [Full Text] [Related]
13. Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats. Pere AK; Krogerus L; Mervaala EM; Karppanen H; Ahonen J; Lindgren L Surgery; 2000 Jul; 128(1):67-75. PubMed ID: 10876188 [TBL] [Abstract][Full Text] [Related]
14. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral. Sijpkens YW; Mallat MJ; Siegert CE; Zwinderman AH; Westendorp RG; de Fijter JW; van Es LA; Paul LC Clin Nephrol; 2001 Feb; 55(2):149-55. PubMed ID: 11269679 [TBL] [Abstract][Full Text] [Related]
15. Mees' lines due to cyclosporin. Siragusa M; Alberti A; Schepis C Br J Dermatol; 1999 Jun; 140(6):1198-9. PubMed ID: 10354113 [No Abstract] [Full Text] [Related]
16. Acute cyclosporine nephrotoxicity in a patient with oral pemphigus vulgaris and HIV infection on antiretroviral therapy. Mignogna MD; Fedele S; Lo Russo L; Bonadies G; Nappa S; Lo Muzio L J Am Acad Dermatol; 2005 Dec; 53(6):1089-90. PubMed ID: 16310079 [No Abstract] [Full Text] [Related]
17. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Jain S; Bicknell GR; Nicholson ML Br J Surg; 2000 Nov; 87(11):1563-8. PubMed ID: 11091246 [TBL] [Abstract][Full Text] [Related]
18. [Value of protecting mitochondrial functions during treatment with cyclosporin A]. Simon N; Albengres E; Barré J; Jolliet P; Urien S; Settaf A; Tillement JP Therapie; 1997; 52(2):151-4. PubMed ID: 9231511 [TBL] [Abstract][Full Text] [Related]
19. Reversible Parkinsonism after chronic cyclosporin treatment in renal transplantation. Ling H; Bhidayasiri R Mov Disord; 2009 Sep; 24(12):1848-9. PubMed ID: 19606490 [No Abstract] [Full Text] [Related]
20. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]